GlobeNewswire by notified

Karolinska Development's portfolio company OssDsign signs long-term contract with largest hospital network in France

Share

STOCKHOLM, SWEDEN – March 23, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has signed a long-term contract to deliver OssDsign Cranial PSI to the largest hospital network in France, Assistance Publique – Hôpitaux de Paris (AP-HP).

OssDsign signed three substantial group purchasing agreements in the U.S. market during the second half of 2021. The company currently has several established contracts in the French market. Assistance Publique – Hôpitaux de Paris (AP-HP) is a world-renowned French university hospital organization that delivers care to 8.3 million individuals annually. Further, the network holds several prestigious clinical research institutions and represents more than 10 % of the cranial surgery market in France. Following competitive procurement rounds, OssDsign has been selected as one of two suppliers and will deliver its innovative cranioplasty product from April 1, 2022, until October 31, 2025.

"OssDsign proves once again that it is a sought-after supplier to the world’s leading surgeons. The company has recently signed several major contracts in the U.S., and it is reassuring to see similar success in France, which is an important part of the European market. There is great potential in OssDsign’s regenerative bone replacement products and each new agreement is a recognition of their unique product portfolio,” says Viktor Drvota. CEO, Karolinska Development.

Karolinska Development's shareholding in OssDsign AB, including an indirect ownership via KCIF Co-Investment Fund, amounts to 10.4 per cent.

For further information, please contact:

Viktor Drvota, CEO, Karolinska Development AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com

Johan Dighed, General Counsel and Deputy CEO, Karolinska Development AB
Phone: +46 70 207 48 26, e-mail: johan.dighed@karolinskadevelopment.com

TO THE EDITORS

About Karolinska Development AB

Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.

Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.

Karolinska Development has a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.

The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.

For more information, please visit www.karolinskadevelopment.com.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

GOGL - Mandatory notification of trade by primary insiders19.5.2022 22:30:00 CEST | Press release

Eligible option holders in Golden Ocean Group Ltd (the “Company”) have today exercised share options in accordance with the terms previously announced. Ulrik Uhrenfeldt Andersen, CEO, has exercised 300,000 share options and subsequently sold 300,000 shares. Following the exercise, Mr. Andersen holds 250,000 share options. Peder Simonsen, CFO, has exercised 75,000 share options and has subsequently sold 75,000 shares. Following the exercise, Mr. Simonsen holds 200,000 share options and 500 shares. Please see the attached forms for notification and public disclosure of transaction attached for details. This notification has been publicly disclosed in accordance with Article 19 of the Market Abuse Regulation section 5-12 of the Norwegian Securities Trading Act. Attachment GOGL - Disclosure of transaction by PDMR

Brunel AGM 202219.5.2022 18:30:00 CEST | Press release

Amsterdam, 19 May 2022 – Brunel International N.V. (Brunel; BRNL), a global provider of flexible workforce solutions and expertise, today announced the voting results of the Annual General Meeting of Shareholders (AGM) of 19 May 2022. The AGM approved all voting items that were on the agenda. The shareholders adopted the financial statements for the 2021 financial year and approved the proposal to distribute a dividend of € 0.45 per share for the 2021 financial year. The dividend, less 15% dividend withholding tax, will be made payable as of 15 June 2022 at ABN AMRO Bank N.V. in Amsterdam. The shares will be quoted ex-dividend on the stock exchange of Euronext Amsterdam as of 23 May 2022. The record date is 24 May 2022 after closing of the stock exchange. Peter de Laat is reappointed as a member of the board of directors for a new term of four years. At the close of the meeting Mr Jan Arie van Barneveld, retired from the supervisory board after having served on the supervisory board fo

Scandinavian Tobacco Group A/S: Share buy-back programme increased to up to DKK 1,000 million19.5.2022 18:15:00 CEST | Press release

Company Announcement No. 35/2022 Copenhagen, 19 May 2022 Share buy-back programme increased to up to DKK 1,000 million The Board of Directors of Scandinavian Tobacco Group A/S has decided to increase the DKK 700 million share buy-back programme that was initiated 10 March 2022 (see company announcement 16/2022) by DKK 300 million. Consequently, the on-going share buy-back programme now has a value of up to DKK 1,000 million. As of 19 May 2022, Scandinavian Tobacco Group had purchased shares of a total value of DKK 128 million under the programme. Prior to the expansion of the share buy-back programme, Scandinavian Tobacco Group A/S holds a total of 1,338,431 treasury shares, corresponding to 1.44% of the total share capital. The purpose of the share buy-back programme remains to adjust the Group’s capital structure and meet obligations relating to the Group’s share-based incentive programme. The Board of Directors intends to propose to the annual general meeting in 2023 that the shares

Scandinavian Tobacco Group A/S reports Q1 results, maintains guidance for 2022 and presents revised Sustainability Strategy19.5.2022 18:15:00 CEST | Press release

Company Announcement No. 34/2022 Copenhagen, 19 May 2022 Interim report, 1 January - 31 March 2022 Scandinavian Tobacco Group A/S reports Q1 results, maintains guidance for 2022 and presents revised Sustainability Strategy For the first quarter of 2022 Scandinavian Tobacco Group delivered 2% negative organic net sales growth and 3% negative organic EBITDA growth in line with the previously communicated expectations for the quarter. The guidance for the full year of an organic EBITDA growth in the range of 0-6% is maintained. The uncertainty related to key assumptions like consumer behaviour, cost inflation and supply-chain stability remains high. The current share buy-back programme is increased by DKK 300 million to reach up to DKK 1,000 million reflecting the strong financial position of Scandinavian Tobacco Group. Consumer demand for handmade cigars in the US remained robust in the quarter though with signs at the end of the quarter of a return to the structural declining volume tre

KBC Group: Publication of transparency notification(s) received by KBC Group NV19.5.2022 18:00:00 CEST | Press release

Press release Outside trading hours – Regulated information* Brussels, 19 May 2022, 18h00 Publication of transparency notification(s) received by KBC Group NV (art. 14, 1st section of the Act of 2 May 2007 concerning the disclosure of significant participations) Summary of the notification(s) KBC Group NV has received a transparency notification on 18 May 2022, which states that FMR LLC holds 3.32% of voting rights in KBC Group, based on’ voting securities’ and ‘financial instruments that are treated as equivalent to voting securities’ combined (compared to 3.01% in the previous notification dd. 6 September 2018). That is the sum of 2.72% for voting securities (compared to 3.01% in the previous notification) and 0.60% for financial instruments that are treated as equivalent to voting securities (compared to 0% in the previous notification). Content of the notification(s) The notification(s) contain(s) following information: Reason for the notification(s): acquisition or disposal of vot